Horizon Therapeutics Public Company Investor Relations Material
Latest events
Q3 2022
Horizon Therapeutics Public Company
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Horizon Therapeutics Public Limited Company
Access all reports
Segment Data
Access more data
Net sales by
Product
TEPEZZA
KRYSTEXXA
RAVICTI
PROCYSBI
Other
Expenses by
Financials
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. It markets IMMUNOCAL to physicians and healthcare professionals in the fields of pediatrics, rheumatology, orthopedics/spine, internal medicine/primary care, physical medicine and rehabilitation/pain management, neurology/neurosurgery, and sports medicine; and IMMUNOTEC to doctors and healthcare professionals in the field of gastroenterology. The company was formerly known as Horizon Pharma Plc and changed its name to Horizon Therapeutics Public Limited Company in April 2019
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
HZNP
Country
🇺🇸 United States